This text is a result of machine translation.
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Many banks have issued documents to stop the intelligent investment advisory business. Insiders: it may be restarted after the regulatory rules are released
Mihayou v. Minmetals trust case will hold a court session, and it is difficult to recover the funds involved in the thunderstorm products
Special representative of the Russian President: Russia will realize technological sovereignty within 10 to 20 years
Huayou cobalt industry: the company has entered the industry chain of global head power batteries such as Ningde times and LG Chemical
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
NASA launches its first rocket from a non domestic commercial launch pad
New energy players flocking to carbon nanotube materials to grab high growth single products
Chang'an Automobile, Huawei and Ningde times jointly released a new generation of intelligent electric vehicle technology platform CHN
EqualOcean | Southern Weekly 2022 'China Greenwashing List'
Yesterday 12:37 PM